F. Gail Bormel
View detailed information about F. Gail Bormel, including compliance records, violations, and related data.
Person Profile
Comprehensive profile of F. Gail Bormel, including their role, qualifications, and regulatory activities.
Recent Records (17)
WARNING_LETTER - Tailstorm Health Inc. dba Medivant Health
WARNING_LETTER
WARNING_LETTER - Empower Clinic Services, LLC dba Empower Pharmacy
WARNING_LETTER
WARNING_LETTER - Exela Pharma Sciences LLC
WARNING_LETTER
WARNING_LETTER - Staska Pharmaceuticals, Inc.
WARNING_LETTER
WARNING_LETTER - ProRx, LLC
WARNING_LETTER
WARNING_LETTER - OSRX, Inc.
WARNING_LETTER
WARNING_LETTER - Fagron Compounding Services
WARNING_LETTER
WARNING_LETTER - Nubratori Inc. dba Nubratori Rx
WARNING_LETTER
WARNING_LETTER - Annovex Pharma, Inc
WARNING_LETTER
WARNING_LETTER - Right Value Drug Stores, LLC dba Carie Boyd Pharmaceuticals
WARNING_LETTER
WARNING_LETTER - Exela Pharma Sciences, LLC
WARNING_LETTER
WARNING_LETTER - ProRx, LLC
WARNING_LETTER
WARNING_LETTER - Wells Pharma of Houston LLC
WARNING_LETTER
WARNING_LETTER - Turbare Manufacturing
WARNING_LETTER
WARNING_LETTER - Empower Clinic Services, LLC dba Empower Pharmacy
WARNING_LETTER
UNTITLED_LETTER - LEESAR, INC
UNTITLED_LETTER
WARNING_LETTER - MedisourceRx
WARNING_LETTER
Related People (2)
Related Office
Person Information
Name
F. Gail Bormel
Title
F.
Role
Regulatory Personnel
ID: 9aba4201-9a1a-4db6-85ef-1f33dc50525d
Get More Insights
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox